Telephone follow-up by pharmacists benefits patients after hospital discharge

A new British Journal of Clinical Pharmacology study illustrates the benefits of having clinical pharmacists follow up, by telephone, with patients at risk of having medication-related issues after hospital discharge. The aim is to help patients manage their medications effectively.

In the study, patients who received such pharmacist-led, post-discharge telephone follow-up were matched with patients in a control group. All patients in the study had been prescribed multiple medicines for the management of their medical conditions.

The intervention reduced 30- and 90-day hospital readmission rates by 9.9 percent and 15.2 percent, respectively, compared with controls. The intervention also had positive effects on time to hospital readmission, length of hospital stay upon readmission, healthcare costs, patient beliefs about medicines, patient adherence to their medications, and patient satisfaction.

"Many patients have difficulty in managing their medicines after discharge from hospital. Telephone follow-up allowed clinical pharmacists to give tailored support to patients according to their individual needs," said senior author Prof. James McElnay, of Queen's University Belfast, in the UK. "This simple intervention had very positive outcomes and was welcomed by patients. We are working to introduce this new approach into routine practice across the hospital service."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New protein platform enhances cancer immunotherapy